ArticleCureus2025
A Less Common but Lethal Encounter: Mixed Autoimmune Hemolytic Anemia Unmasking Angioimmunoblastic T-cell Lymphoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hemolytic anemia (AIHA) is a spectrum of acquired hemolytic disorders caused by autoantibodies targeting red blood cells, leading to their destruction and anemia. Mixed AIHA, characterized by both warm and cold autoantibodies, is a rare and complex condition, often presenting diagnostic challenges. Angioimmunoblastic T-cell lymphoma (AITL), a subtype of peripheral T-cell lymphoma, is also uncommon and can be associated with autoimmune cytopenias. We present a case of a 48-year-old male patient diagnosed with mixed AIHA and AITL after presenting with generalized weakness, jaundice, and bicytopenia. Diagnosis was confirmed through positive Coombs tests for warm and cold antibodies, lymph node biopsy, and imaging. Despite initial response to glucocorticoids, the patient experienced complications following chemotherapy initiation, leading to a fatal outcome. This case highlights the importance of early recognition of mixed AIHA and AITL and the complexities involved in their management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.